Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Wednesday, March 26, 2025 · 797,239,035 Articles · 3+ Million Readers

Biliary Tract Cancer Global Market Report 2025: Unveiling Key Market Dynamics, Projections, And Prime Industry Players

The Business Research Company

The Business Research Company

The Business Research Company's Biliary Tract Cancer Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! ”
— The Business Research Company

LONDON, GREATER LONDON, UNITED KINGDOM, March 24, 2025 /EINPresswire.com/ -- The biliary tract cancer market has experienced pronounced growth in recent years, with projections showing an upward trend. The market size, which sat at $0.67 billion in 2024, is expected to grow to $0.72 billion in 2025 at a compound annual growth rate CAGR of 7.5%. The growth during the historic period can be largely linked to the escalating incidence of biliary tract cancer, a steady increase in the demand for effective therapies, the growing prevalence of obesity, an aging global population, and burgeoning investments in research and development.

Is The Biliary Tract Cancer Market Set To Witness Substantial Growth?

Further growth is anticipated in the foreseeable future with projected market size reaching $0.95 billion in 2029, indicating a CAGR of 7.3%. This forecasted growth can be majorly tied to alterations in lifestyles, awareness development, initiatives promoting early detection, favorable reimbursements policies, and broadening government policies. Notable trends during the forecast period include advancements in diagnosis and treatment methodologies, acceptance of immunotherapy, growing demand for precision medicine, changing treatment approaches, and progress in the development of biomarker-based therapies.

Get Your Free Sample of The Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=21114&type=smp

What Drives The Biliary Tract Cancer Market Growth?

One of the pivotal drivers propelling the growth of the biliary tract cancer market forward is the increasing prevalence of obesity, a chronic medical condition typified by an excessive accumulation of body fat detrimental to health. The upswing in obesity prevalence is attributed to factors spanning physical inactivity, psychological influences, aging, and genetic and biological factors. Obesity ignites chronic inflammation, insulin resistance, and excess bile acid secretion which foster DNA damage and tumor growth.

The escalating cases of obesity are further disrupting hormones and metabolism, nurturing an environment within the biliary tract that is prone to cancer. Highlighting this, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, the number of states with an adult obesity rate of 35% or higher had risen to 22, up from 19 in 2021. Consequently, the growing prevalence of obesity is a major catalyst fueling the growth of the biliary tract cancer market.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/biliary-tract-cancer-global-market-report


Who Are The Key Players In The Biliary Tract Cancer Market?

Key industry players include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Eli Lily and Company, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Servier Pharmaceuticals, Jazz Pharmaceuticals plc, Incyte Corporation, BeiGene LTD., Zymeworks, Basilea Pharmaceutica Ltd., Taiho Oncology Inc., RenovoRx Inc., TransThera Sciences Inc., QED Therapeutics Inc., Helsinn Group, and more.

What Are The Emerging Trends In The Biliary Tract Cancer Market?

The major companies operating in the biliary tract cancer market are focusing on nurturing advancements in combination treatment to extend efficacy and improve patient outcomes. During November 2023, U.S. pharmaceutical company, Merck & Co. Inc., received the U.S. Food and Drug Administration FDA approval for KEYTRUDA pembrolizumab in combination with gemcitabine and cisplatin for treating patients with locally advanced unresectable or metastatic biliary tract cancer.

How Is The Biliary Tract Cancer Market Segmented?

- By Cancer Type: Intrahepatic Bile Duct Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer
- By Treatment: Chemotherapy, Targeted Therapy, Immunotherapy
- By End-User: Hospitals, Specialty Cancer Centres, Ambulatory Surgical Centres, Other End-Users

Into subsegments:
- By Intrahepatic Bile Duct Cancer: Peripheral Intrahepatic Bile Duct Cancer, Hilar Intrahepatic Bile Duct Cancer
- By Extrahepatic Bile Duct Cancer: Perihilar Bile Duct Cancer, Distal Bile Duct Cancer
- By Gallbladder Cancer: Localized Gallbladder Cancer, Advanced Gallbladder Cancer

What Is The Regional Analysis Of Biliary Tract Cancer Market?

In 2024, North America led the charge in the biliary tract cancer market, with Asia-Pacific touted to be the fastest-growing region during the projection period. The report covers the biliary tract cancer market in Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

For more market reports from The Business Research Company, visit:
Bone Grafts and Substitutes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bone-grafts-and-substitutes-global-market-report

Cancer Tumor Profiling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Cancer biologics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report


About The Business Research Company
Empower your decision-making with The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has earned a reputation for comprehensive, data-packed research and insights. Our 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders equip you with the intelligence to stay ahead of the curve.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Contact us at info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Watch us on YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Explore the Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Powered by EIN Presswire

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry, International Organizations, Technology, World & Regional

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release